Skip to main content
Home
FULL MENU Close Menu
Home
Home

HT Staff

News

Health Canada approves two tests for CML patients

Author:
HT Staff
Publish date: November 15, 2018

Health Canada has approved the use of two tests designed to detect BCR-ABL transcripts in patients with chronic myeloid leukemia (CML)—the MRDx®...

  • Read More

News

Markers associated with efficacy of malaria vaccine

Author:
HT Staff
Publish date: November 14, 2018

New research has revealed markers associated with efficacy of the RTS,S/AS01E malaria vaccine (Mosquirix™). The study suggests malaria protection...

  • Read More

News

Diet change can improve survival in obese mice with ALL

Author:
HT Staff
Publish date: November 14, 2018

Switching to a low-fat diet can improve survival in obese mice with acute lymphoblastic leukemia (ALL), according to new research. Diet-induced...

  • Read More

News

FDA clears instrument for blood typing, screening

Author:
HT Staff
Publish date: November 13, 2018

The U.S.

  • Read More

News

‘Compelling’ new target found for monocytic AML

Author:
HT Staff
Publish date: November 11, 2018

Efforts to determine why immune checkpoint blockade is not successful in treating leukemia have resulted in a “compelling” new target to treat...

  • Read More

News

Triplet improves PFS in relapsed/refractory MM

Author:
HT Staff
Publish date: November 10, 2018

Adding elotuzumab to pomalidomide and low-dose dexamethasone can improve progression-free survival (PFS) in patients with relapsed/refractory...

  • Read More

News

CAR T therapy for MM receives RMAT designation

Author:
HT Staff
Publish date: November 9, 2018

P-BCMA-101, an autologous chimeric antigen receptor (CAR) T-cell therapy being developed to treat patients with relapsed/refractory multiple...

  • Read More

News

Vaccine inhibits thrombus formation in mice

Author:
HT Staff
Publish date: November 9, 2018

Investigators designed an antiplatelet vaccine they say could be a novel therapy to prevent recurrent ischemic stroke. The vaccine inhibits...

  • Read More

News

Combo worsens platelet recovery in MDS

Author:
HT Staff
Publish date: November 8, 2018

Results from the phase 3 SUPPORT trial suggest there is no role for the combination of eltrombopag and azacitidine in patients with intermediate-...

  • Read More

News

Molecule enhances PI activity in multiple myeloma

Author:
HT Staff
Publish date: November 8, 2018

Researchers say they have identified a new class of protein disulfide isomerase (PDI) inhibitors that sensitize multiple myeloma (MM) cells to...

  • Read More

News

FDA clears portable hematology analyzer

Author:
HT Staff
Publish date: November 8, 2018

The U.S.

  • Read More

News

Selinexor on fast track for DLBCL

Author:
HT Staff
Publish date: November 8, 2018

The U.S.

  • Read More

News

Quizartinib receives accelerated assessment for AML

Author:
HT Staff
Publish date: November 7, 2018

The European Medicines Agency has granted accelerated assessment to the marketing authorization application (MAA) for the FLT3 inhibitor...

  • Read More

News

Sandoz won’t seek U.S. approval for rituximab biosimilar

Author:
HT Staff
Publish date: November 6, 2018

Sandoz has decided not to pursue U.S. approval for its rituximab product (GP2013), a proposed biosimiliar of Rituxan/Mabthera. GP2013 (Rixathon,...

  • Read More

News

CPI-0610 receives fast track designation for MF

Author:
HT Staff
Publish date: November 6, 2018

The U.S.

  • Read More

Pages

  • « first
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • last »

Privacy Policy

Do Not Sell My Personal Information

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2021 Frontline Medical Communications Inc., Parsippany, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close